
Continuous PEG-Asparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL
A study published in the Journal of Clinical Oncology found that a continuous dosing schedule of PEG-asparaginase (PEGasp) in children with acute lymphoblastic leukemia (ALL) reduced hypersensitivity reactions and antibody formation compared to a noncontinuous schedule. The study included 818 patients aged 1-18, with 312 in the medium-risk arm. Results showed fewer hypersensitivity reactions in…